Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

How is LSDs prevalence & epidemiology different in our region?

Global use of RAM and Thromboprophylaxis in hospitalized patients

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

Benefit of Prophylaxis for High-Risk Surgical Patients

Pompe

About Type 2 Inflammation – Nasal Polyps

Slowing of brain atrophy with Teriflunomide

APSC Consensus Recommendations on Dyslipidemia

Independent Risk Factors for Venous Thromboembolism